The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

Journal of Experimental Medicine

Volumn 189, Issue 9, 1999, Pages 1399-1412

  Li, Shaoguang ^a   Ilaria Jr , Robert L ^b,e   Million, Ryan P ^a   Daley, George Q ^c   Van Etten, Richard A ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d CENTER FOR BLOOD RESEARCH   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Abelson virus; Chronic myelogenous leukemia; Mouse cancer model; Retrovital vector

Indexed keywords

COMPLEMENTARY DNA; FLUOROURACIL; INTERLEUKIN 3; PROTEIN TYROSINE KINASE; VIRUS VECTOR;

ABELSON MURINE LEUKEMIA ONCOVIRUS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER MODEL; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; LEUKEMOGENESIS; MOUSE; NONHUMAN; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RETROVIRUS;

ANIMALS; CELL DIVISION; CELL LINE, TRANSFORMED; DISEASE MODELS, ANIMAL; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTES; MICE; MICE, INBRED BALB C; ONCOGENES; PROTEIN ISOFORMS; PROTEIN-TYROSINE KINASES; SYNDROME;

EID: 0033519238     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.9.1399     Document Type: Article

References (60)

1. Fainstein, E., C. Marcelle, A. Rosner, E. Canaani, R.P. Gale, O. Dreazen, S.D. Smith, and C.M. Croce. 1987. A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature. 330:386-388.
2. Groffen, J., J.R. Stephenson, N. Heisterkamp, A. de Klein, C.R. Bartram, and G. Grosveld. 1984. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 36:93-99.
3. Saglio, G., A. Guerrasio, C. Rosso, A. Zaccaria, A. Tassinari, A. Serra, G. Rege-Cambrin, U. Mazza, and F. Gavosto. 1990. New type of Bcr/Abl junction in Philadelphia chromosomepositive chronic myelogenous leukemia. Blood. 76:1819-1824.
4. Van Etten, R.A. 1993. The molecular pathogenesis of the Philadelphia-positive leukemias: implications for diagnosis and therapy. In Leukemia: Advances in Treatment and Research. E.J. Freireich and H. Kantarjian, editors. Kluwer Academic Publishers, Norwood, MA. 294-325.
5. Melo, J.V. 1996. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 88:2375-2384.
6. Chen, S.J., G. Flandrin, M.T. Daniel, F. Valensi, L. Baranger, D. Grausz, A. Bernheim, Z. Chen, F. Sigaux, and R. Berger. 1988. Philadelphia-positive leukemia: lineage promiscuity and inconsistently rearranged breakpoint cluster region. Leukemia. 2:261-273.
7. Hirsch-Ginsberg, C., C. Childs, K.-S. Chang, M. Beran, A. Cork, J. Reuben, E.J. Freireich, L.C.M. Chang, F.J. Bollum, J. Trujillo, and S.A. Stass. 1988. Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemia. Blood. 71:186-195.
8. Schaefer-Rego, K., Z. Arlin, L.G. Shapiro, J.G. Mears, and D. Leibovvitz. 1988. Molecular heterogeneity of adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer Res. 48:866-869.
9. Chan, L.C., K.K. Karhi, S.I. Rayter, N. Heisterkamp, S. Eridani, R. Powles, S.D. Lawler, J. Groffen, J.G. Foulkes, M.F. Greaves, and L.M. Wiedemann. 1987. A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature. 325:635-637.
10. Kurzrock, R., M. Shtalrid, M. Talpaz, W.S. Kloetzer, and J.U. Gutterman. 1987. Expression of c-abl in Philadelphia-positive acute myelogenous leukemia. Blood. 70:1584-1588.
11. Selleri, L., M. von Lindern, A. Hermans, D. Meijer, G. Torelli, and G. Grosveld. 1990. Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript. Blood. 75:1146-1153.
12. Zaccaria, A., A. Tassinari, N. Testoni, F. Lauria, S. Tura, R. Algeri, A. Guerrasio, C. Rosso, and G. Saglio. 1990. Alternative BCR/ABL transcripts in chronic myeloid leukemia. Blood. 76:1663-1665.
13. Melo, J.V., H. Myint, D.A. Galton, and J.M. Goldman. 1994. P190 BCR-ABL chronic myeloid leukemia: the missing link with chronic myelomonocytic leukemia? Leukemia. 8:208-211.
14. Pane, F., F. Frigeri, M. Sindona, L. Luciano, F. Ferrara, R. Cimino, G. Meloni, G. Saglio, F. Salvatore, and B. Rotoli. 1996. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/ A2 junction). Blood. 88:2410-2414.
15. Emilia, G., M. Luppi, R. Marasca, and G. Torelli. 1997. Relationship between BCR/ABL fusion proteins and leukemia phenotype. Blood. 89:3889.
16. Mittre, H., P. Leymarie, M. Macro, and M. Leporrier. 1997. A new case of chronic myeloid leukemia with c3/a2 BCR/ABL junction. Is it really a distinct disease? Blood. 89:4239-4241.
17. Briz, M., C. Vilches, R. Cabrera, R. Fores, and M.N. Fernandez. 1997. Typical chronic myelogenous leukemia with e19a2 junction BCR/ABL transcript. Blood. 90:5024-5025.
18. Lugo, T.G., A. Pendergast, A.J. Muller, and O.N. Witte. 1990. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science. 247:1079-1082.
19. BCR/ABL is not required for transformation of hematopoietic factor-dependent cells. Blood. 86:3897-3904.
20. McLaughlin, J., E. Chianese, and O.N. Witte. 1987. In vitro transformation of immature hematopoietic cells by the P210 bcr/abl oncogene product of the Philadelphia chromosome. Prof. Natl. Acad. Sci. USA. 84:6558-6562.
21. McLaughlin, J., E. Chianese, and O.N. Witte. 1989. Alternative forms of the bcr-abl oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol. Cell. Biol. 9:1866-1874.
22. Okuda, K., T.G. Golub, D.G. Gilliland, and J.D. Griffin. 1996. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. Oncogene. 13:1147-1152.
23. Kaplan, M.H., U. Schindler, S.T. Smiley, and M.J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 4:313-319.
24. BCR/ABL induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem. 271:31704-31710.
25. Van Etten, R.A. 1998. Animal models of chronic myelogenous leukemia. In Medical Management of Chronic Myelogenous Leukemia. M. Talpaz and H. Kantarjian, editors. Marcel Dekker, Inc., New York. 77-101.
26. bcr/abl gene of the Philadelphia chromosome. Science. 247:824-830.
27. Kelliher, M.A., J. McLaughlin, O.N. Witte, and N. Rosenberg. 1990. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and bcr/abl. Proc. Natl. Acad. Sci. USA. 87:6649-6653.
28. Elefanty, A.G., and S. Cory. 1992. Hematologic disease induced in BALB/c mice by a bcr/abl retrovirus is influenced by infection conditions. Mol. Cell. Biol. 12:1755-1763.
29. Gishizky, M.I., J. Johnson-White, and O.N. Witte. 1993. Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice. Proc. Natl. Acad. Sci. USA. 90:3755-3759.
30. Elefanty, A.G., I.K. Hariharan, and S. Cory. 1990. bcr-abl, the hallmark of chronic myeloid leukemia in man, induces multiple hematopoietic neoplasms in mice. EMBO (Eur. Mol. Biol. Organ.) J. 9:1069-1078.
31. Van Etten, R.A. 1991. Distinct effect of expression of the ALL-specific form of BCR/ABL, P190BCR/ABL, in murine bone marrow. Blood. 78(Suppl. 1):78a. (Abstr.)
32. Kelliher, M., A. Knott, J. McLaughlin, O.N. Witte, and N. Rosenberg. 1991. Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ ABL oncogene. Mol. Cell. Biol. 11:4710-4716.
33. Pear, W.S., J. Miller, L.W. Xu, B. Soffer, R. Ren, X.M. Long, J. Aster, R. Bronson, and D. Baltimore. 1997. Murine models for studying the pathogenesis of chronic myelogenous leukemia. Blood. 90(Suppl. 1):393a. (Abstr.)
34. Hawley, R.G., A.Z.C. Fong, B.F. Bums, and T.S. Hawley. 1992. Transplantable myeloproliferarive disease induced in mice by an interleukin 6 retrovirus. J. Exp. Med. 176:1149-1163.
35. Van Etten, R.A., J. Debnath, H. Zhou, and J.M. Casasnovas. 1995. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro. Oncogene. 10:1977-1988.
36. Finer, M.H., T.J. Dull, L. Qin, D. Farson, and M. Roberts. 1994. kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood. 83:43-50.
37. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:8392-8396.
38. Luskey, B.D., M. Rosenblatt, K. Zsebo, and D.A. Williams. 1992. Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood. 80:396-402.
39. Kotani, H., P.B. Newton, S. Zhang, Y.L. Chiang, E. Otto, L. Weaver, R.M. Blaese, and W. F. Anderson. 1994. Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 5:19-28.
40. Mayer, B.J., and D. Baltimore. 1994. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol Cell. Biol. 14:2883-2894.
41. Daley, G., and D. Baltimore. 1988. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210 bcr/abl protein. Proc. Natl. Acad. Sc. USA. 85:9312-9316.
42. Laneuville, P., N. Heisterkamp, and J. Groffen. 1991. Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line. Oncogene. 6:275-282.
43. Daley, G.Q., R.A. Van Etten, and D. Baltimore. 1991. Blast crisis in a murine model of chronic myelogenous leukemia. Proc. Natl. Acad. Sci. USA. 88:11335-11338.
44. Scott, M.L., R.A. Van Etten, G.Q. Daley, and D. Baltimore. 1991. v-abl causes hematopoietic disease distinct from that caused by bcr-abl. Proc. Natl. Acad. Sci. USA. 88:6506-6510.
45. Siminovitch, L., E.A. McCulloch, and J.E. Till. 1963. Distribution of colony-forming cells among spleen colonies. J. Cell. Comp. Physiol. 62:327.
46. Kelliher, M.A., D.J. Weckstein, A.G. Knott, H.H. Wortis, and N. Rosenberg. 1993. ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice. Oncogene. 8:1249-1256.
47. Rosenberg, N., and D. Baltimore. 1976. A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J. Exp. Med. 143:1453-1463.
48. Fialkow, P.J., A.M. Denman, R.J. Jacobson, and M.N. Lowenthal. 1978. Chronic myelocytic leukemia: origin of some lymphocytes from leukemic stem cells. J. Clin. Invest. 62:815-823.
49. Secker-Walker, L.M., H.M.G. Cooke, P.J. Browett, C.A. Shippey, J.D. Norton, E. Coustan-Smith, and A.V. Hoffbrand. 1988. Variable Philadelphia breakpoints and potential lineage restriction of bcr rearrangement in acute lymphoblastic leukemia. Blood. 72:784-791.
50. Turhan, A.G., C.J. Eaves, D.K. Kalousek, A.C. Eaves, and R.K. Humphries. 1988. Molecular analysis of clonality and bcr rearrangements in Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 71:1495-1498.
51. Tachibana, N., S.C. Raimondi, S.J. Lauer, P. Sartain, and L.W. Dow. 1987. Evidence for a multipotential stem cell disease in some childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 70:1458-1461.
52. Dow, L.W., N. Tachibana, S.C. Raimondi, S.J. Lauer, O.N. Witte, and S.C. Clark. 1989. Comparative biochemical and cytogenetic studies of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and other 22q11 variants. Blood. 73:1291-1297.
53. Schenk, T.M., A. Keyhani, S. Bottcher, K.O. Kliche, A. Goodacre, J.Q. Guo, R.B. Arlinghaus, H.M. Kantarjian, and M. Andreeff. 1998. Multilineage involvement of Philadelphia chromosome positive lymphoblastic leukemia. Leukemia. 12:666-674.
54. Tidmarsh, G.F., S. Heimfeld, C.A. Whitlock, I.L. Weissman, and C.E. Muller-Sieburg. 1989. Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for Abelson leukemia virus targets. Mol. Cell. Biol. 9:2665-2671.
55. Shinefeld, L.A., V.L. Sato, and N.E. Rosenberg. 1980. Monoclonal rat anti-mouse brain antibody detects Abelson murine leukemia virus target cells in mouse bone marrow. Cell. 20:11-17.
56. Whitlock, C.A., and O.N. Witte. 1981. Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential. J. Virol. 40:577-584.
57. Green, P.L., D.A. Kaehler, and R. Risser. 1987. Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis. J. Virol. 61:2192-2197.
58. Scherle, P.A., K. Dorshkind, and O.N. Witte. 1990. Clonal lymphoid progenitor cell lines expressing the BCR/ABL oncogene retain full differentiative function. Proc. Natl. Acad. Sci. USA. 87:1908-1912.
59. Voncken, J.W., C. Morris, P. Pattengale, G. Dennert, C. Kikly, J. Groffen, and N. Heisterkamp. 1992. Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice. Blood. 79:1029-1036.
60. Morrison, S.J., and I.L. Weissman. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1:661-673.